JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DE MARCO, T. J.
Right arrow Articles by LEVINE, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DE MARCO, T. J.
Right arrow Articles by LEVINE, R. R.
Journal of Pharmacology And Experimental Therapeutics, Vol. 169, Issue 1, 142-151, 1969
Copyright © 1969 by American Society for Pharmacology and Experimental Therapeutics


ROLE OF THE LYMPHATICS IN THE INTESTINAL ABSORPTION AND DISTRIBUTION OF DRUGS

THOMAS J. DE MARCO 1 and RUTH R. LEVINE 1

1 Department of Pharmacology and Experimental Therapeutics, Boston University Medical Center, Boston, Massachusetts

mesenteric lymph collected after intraduodenal administration of p-aminosahicylic acid (PAS) contained relatively more unmetabolized PAS than did thoracic lymph or plasma sampled after either duodenal or i.v. administration, indicating direct absorption of the drug via the lymphatic system. That tetracycline also can be absorbed directly into intestinal lymph was demonstrated histologically by the appearance of fluorescence in the central lacteals only in the intestinal area containing the drug. However, under normal conditions. the lymphatic route accounted for only a small percentage of the total absorption of the two drugs chosen as models. The difference in absorption potential between lymph and blood capillaries is related to differences in rates of flow within the two circulatory systems. Increasing lymph flow by oral administration of the lymphogogue, tripalmitin, increased the quantities of both drugs absorbed via intestinal lymph. Decreasing intestinal blood flow by ligation of the superior mesenteric vein increased the proportion of PAS absorbed through the lymphatics. After i.v. administration of PAS, the concentrations of both free and total PAS were the same in plasma and lymph even though PAS is bound to plasma protein. The concentration of tetracycline was 5 times higher in lymph than in blood 10 minutes after its i.v. administration and did not equal that in blood until 90 minutes. This may have importance in the treatment of diseases associated with the lymphatic system.

Submitted on November 15, 1968
Accepted on May 13, 1969







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics.